PHK
DTIL icon

Point72 Hong Kong’s Precision BioSciences DTIL Stock Holding History

Point72 Hong Kong’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21
Closed -$2K – 2033
2022
Q1 		$2K Buy
+21
New +$2.85K ﹤0.01% 1724
2021
Q4 		– Sell
-64
Closed -$22K – 2008
2021
Q3 		$22K Buy
+64
New +$21.7K ﹤0.01% 1681
2021
Q2 		– Sell
-20
Closed -$6K – 2017
2021
Q1 		$6K Buy
+20
New +$7K ﹤0.01% 1635
2020
Q3 		– Sell
-140
Closed -$35K – 1267
2020
Q2 		$35K Buy
140
+130
+1,300% +$28.5K ﹤0.01% 794
2020
Q1 		$2K Buy
+10
New +$2.62K ﹤0.01% 844

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Point72 Hong Kong's DTIL Position: Q2 2022 in Review

Point72 Hong Kong sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 21 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in DTIL in Q1 2020 and held it in 5 quarters. The position peaked at $35K in Q2 2020. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • Point72 Hong Kong reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 21 Precision BioSciences shares in Q2 2022, an estimated $2K.
  • Point72 Hong Kong first reported a position in Precision BioSciences in Q1 2020 and held it in 5 quarters.
  • Point72 Hong Kong's Precision BioSciences position peaked at $35K in Q2 2020.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.